Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

209 ARTÍCULOS , VIENDO DEL 151 AL 165

N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities

Bavarsad Shahripour R, Harrigan MR, Alexandrov AV.

Brain Behav. 2014 Mar;4(2):108-22. doi: 10.1002/brb3.208. Epub 2014 Jan 13.

Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies

Balint B, Jarius S, Nagel S, Haberkorn U, Probst C, Blöcker IM, Bahtz R, Komorowski L, Stöcker W, Kastrup A, Kuthe M, Meinck HM.

Neurology. 2014 Apr 29;82(17):1521-8. doi: 10.1212/WNL.0000000000000372. Epub 2014 Apr 2.

Ophthalmic presentation in the emergency department: a case report of a girl with "shimmering eyes"

Krivochenitser R, Lemma Y, Wynn B, Jones JS.

J Emerg Med. 2014 Jun;46(6):e163-5. doi: 10.1016/j.jemermed.2014.01.031. Epub 2014 Mar 31.

'Dancing eyes, dancing feet syndrome' in small cell lung carcinoma

Sharma C, Acharya M, Kumawat BL, Kochar A.

BMJ Case Rep. 2014 Apr 23;2014:bcr2014203926. doi: 10.1136/bcr-2014-203926.

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

Rossi M, Perez-Lloret S, Doldan L, Cerquetti D, Balej J, Millar Vernetti P, Hawkes H, Cammarota A, Merello M.

Eur J Neurol. 2014 Apr;21(4):607-15. doi: 10.1111/ene.12350. Epub 2014 Feb 12.

Distal weakness with respiratory insufficiency caused by the m.8344A > G "MERRF" mutation

Blakely EL, Alston CL, Lecky B, Chakrabarti B, Falkous G, Turnbull DM, Taylor RW, Gorman GS.

Neuromuscul Disord. 2014 Jun;24(6):533-6. doi: 10.1016/j.nmd.2014.03.011. Epub 2014 Apr 1.

Compound mitochondrial DNA mutations in a neurological patient with ataxia, myoclonus and deafness

Park JH, Yoon BR, Kim HJ, Lee PH, Choi BO, Chung KW.

J Genet. 2014 Apr;93(1):173-7. doi: 10.1007/s12041-014-0317-8.

Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review

Rossi M, Perez-Lloret S, Cerquetti D, Merello M.

Mov Disord Clin Pract. 2014 Jun 6;1(3):154-160. doi: 10.1002/mdc3.12042. eCollection 2014 Sep.

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, Muscal E, Deiva K, Andersen E, Eyre MR, Eleftheriou D, Brogan PA, Kneen R, Alper G, Anlar B, Wassmer E, Heineman K, Hemingway C, Riney CJ, Kornberg A, Tardieu M, Stocco A, Banwell B, Gorman MP, Benseler SM, Lim M.

Neurology. 2014 Jul 8;83(2):142-50. doi: 10.1212/WNL.0000000000000570. Epub 2014 Jun 11.

Ataxia plus myoclonus in a 23-year-old patient due to STUB1 mutations

Cordoba M, Rodriguez-Quiroga S, Gatto EM, Alurralde A, Kauffman MA.

Neurology. 2014 Jul 15;83(3):287-8. doi: 10.1212/WNL.0000000000000600. Epub 2014 Jun 13.

Levatiracetam for the management of Lance-Adams syndrome

Ilik F, Kemal Ilik M, Cöven I.

Iran J Child Neurol. 2014 Spring;8(2):57-9.

Opsoclonus-myoclonus syndrome attributable to West Nile encephalitis: a case report

Bîrluţiu V, Bîrluţiu RM.

J Med Case Rep. 2014 Jun 26;8:232. doi: 10.1186/1752-1947-8-232.

West nile virus encephalitis induced opsoclonus-myoclonus syndrome

Cooper CJ, Said S.

Neurol Int. 2014 Apr 22;6(2):5359. doi: 10.4081/ni.2014.5359. eCollection 2014 Apr 22.

Severe 5,10-methylenetetrahydrofolate reductase deficiency and two MTHFR variants in an adolescent with progressive myoclonic epilepsy

D'Aco KE, Bearden D, Watkins D, Hyland K, Rosenblatt DS, Ficicioglu C.

Pediatr Neurol. 2014 Aug;51(2):266-70. doi: 10.1016/j.pediatrneurol.2014.04.005. Epub 2014 Apr 13.

Klinefelter syndrome associated myoclonus

Buijink AW, Koelman JH, Meissner A, Stegenga ME, van Rootselaar AF.

Parkinsonism Relat Disord. 2014 Nov;20(11):1315-6. doi: 10.1016/j.parkreldis.2014.09.012. Epub 2014 Sep 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias